The Advanced Regenerative Manufacturing Institute (ARMI) brings together a consortium of over 100 partner organizations from industry, government, academia and ...
New process targets improvements for defense, vehicles and health productsCredit: Srinivasan Chandrasekar/Purdue University WEST LAFAYETTE, Ind. - Most people may ...
Credit: Dana-Farber Cancer Institute BOSTON - A combination of two drugs - one of them an immunotherapy agent - could ...
Credit: Kent State University Many homes today include safety devices like smoke, radon and carbon monoxide detectors to warn us ...
Only few study participants received approval-compliant treatment; extent of added benefit therefore non-quantifiable Squamous cell carcinoma is one of the ...
This article by Dr. Kumud Joshi et al. is published in Current Drug Delivery, Volume 16 , Issue 3, 2019 ...
Advancement in technology is making life easier. However, innovation in nano-materials has made them important enough and now they are ...
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with ...
Credit: Hannes Baur Representing a group of successful biocontrol agents for various pest fruit flies, a parasitic wasp genus remains ...
Credit: Xiaohu HUANG The assimilation of aerosol optical depth (AOD) observational data from the Chinese satellite Fengyun-3A (FY-3A) can significantly ...
Credit: Case Western Reserve University School of Medicine Sports concussions, Parkinson's disease, and hormone therapy for cancer - all can ...
Credit: Children's Hospital Colorado Aurora, Colo. (Nov. 12, 2018) - Children's Hospital Colorado (Children's Colorado) pediatric gastroenterologist, Michael Narkewicz, MD, ...
Credit: Worcester Polytechnic Institute Worcester, Mass. - With a $1.08 million contract award from the United States Advanced Battery Consortium ...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Treatment with the cyclin dependent kinase (CDK) ...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP ...
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) ...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors ...
Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according ...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Most people with lung cancer are unaware ...
The ability to translate the genetic code into proteins is an essential step in all living organisms. A cornerstone of ...
